Mara AspinallManaging Director at Health Catalysts Group
Mara Aspinall is a biotech industry executive and healthcare pioneer. She is president and CEO of HealthCatalysts, a firm dedicated to the growth of new healthcare companies. Aspinall is also executive chairman of GenePeeks, a computational genomics company creating a paradigm shift in genetic testing and personalized medicine. GenePeeks’ proprietary technology can identify the risk of passing on monogenic disease to progeny pre-conception through data mining the maternal and paternal genomes.
Aspinall is the former president and CEO of Ventana Medical Systems division of Roche, worldwide leader in development and commercialization of tissue-based cancer diagnostics. She previously spent 12 years as president of Genzyme Genetics and Genzyme Pharmaceuticals. Genzyme Genetics set the standard for quality in the diagnostics industry, leading the market in prenatal and cancer testing. The business was sold to LabCorp for $1 billion.